The US Food and Drug Administration (FDA) has issued a Class I recall for Medtronic’s NIM Vital Nerve Monitoring System due ...

Medtronic is a compelling investment with its diverse revenue streams, strong growth, and promising product pipeline at an ...

Across the healthcare landscape, more and more conversations are focusing on health inequity. Specific to pulse oximetry, recent research, media, and regulatory discussions have been raising awareness ...

Medtronic announced results from a survey indicating that AI and VR could help reduce disparities in access to surgical ...

Ajizian, Medtronic’s chief medical officer of acute care and monitoring, revealed his departure on LinkedIn Thursday. The executive worked in the patient monitoring business before Medtronic ...

Medtronic has been consistently growing at ... From catheters to neurostimulators to continuous glucose monitoring devices, the company has a broad range of products in its portfolio, and it's ...

Medtronic's product portfolio is comprised of a variety of life-saving and life-improving medical devices that include implantable defibrillators, heart valves, insulin pumps, glucose monitoring ...

Medtronic found that dropping, bumping, or hits to the MiniMed device could result in a shortened battery life.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Medtronic GI Genius™ system demonstrates AI's capacity to improve diagnostic accuracy by serving as a second set of eyes for clinicians, demonstrating 99.7%-100% sensitivity rate when screening ...

Sept 19 (Reuters) - Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's (MDT.N), opens new tab patent rights in nerve ...